U.S. flag

An official website of the United States government

GTR Home > Genes

HSPG2 heparan sulfate proteoglycan 2

Gene ID: 3339, updated on 3-Nov-2024
Gene type: protein coding
Also known as: PLC; SJA; SJS; HSPG; SJS1; PRCAN

Summary

This gene encodes the perlecan protein, which consists of a core protein to which three long chains of glycosaminoglycans (heparan sulfate or chondroitin sulfate) are attached. The perlecan protein is a large multidomain proteoglycan that binds to and cross-links many extracellular matrix components and cell-surface molecules. It has been shown that this protein interacts with laminin, prolargin, collagen type IV, FGFBP1, FBLN2, FGF7 and transthyretin, etc., and it plays essential roles in multiple biological activities. Perlecan is a key component of the vascular extracellular matrix, where it helps to maintain the endothelial barrier function. It is a potent inhibitor of smooth muscle cell proliferation and is thus thought to help maintain vascular homeostasis. It can also promote growth factor (e.g., FGF2) activity and thus stimulate endothelial growth and re-generation. It is a major component of basement membranes, where it is involved in the stabilization of other molecules as well as being involved with glomerular permeability to macromolecules and cell adhesion. Mutations in this gene cause Schwartz-Jampel syndrome type 1, Silverman-Handmaker type of dyssegmental dysplasia, and tardive dyskinesia. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2014]

Associated conditions

See all available tests in GTR for this gene

DescriptionTests
Lethal Kniest-like syndrome
MedGen: C1857100OMIM: 224410GeneReviews: Not available
See labs
Schwartz-Jampel syndrome type 1
MedGen: C4551479OMIM: 255800GeneReviews: Not available
See labs

Genomic context

Location:
1p36.12
Sequence:
Chromosome: 1; NC_000001.11 (21822244..21937310, complement)
Total number of exons:
103

Links

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.